Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis
Objectives To examine company characteristics associated with better transparency and to apply a tool used to measure and improve clinical trial transparency among large companies and drugs, to smaller companies and biologics.Design Cross-sectional descriptive analysis.Setting and participants Novel...
Main Authors: | Joseph S Ross, Jennifer Miller, Michelle M Mello, Cary P Gross, Deborah Lincow, Catherine Yang, Sydney A Axson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-07-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/11/7/e053248.full |
Similar Items
-
Correction: Assessing the effect of empathy-enhancing interventions in health education and training: a systematic review of randomised controlled trials
by: Joseph S Ross, et al.
Published: (2021-07-01) -
Change Management in a biopharmaceutical company
by: Terblanche, Thersia
Published: (2021) -
Change Management in a Biopharmaceutical Company
by: Terblanche, Thersia
Published: (2021) -
Strategic aspects of staffing industrial biopharmaceutical companies
by: A. S. Glazkova, et al.
Published: (2020-01-01) -
An Exploration of Business Model Components in Biopharmaceutical Companies
by: Maryam Goodarzi, et al.
Published: (2020-01-01)